Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Alzheimer's Disease
100%
Lipoxin A4 (LXA4)
100%
Inflammation
66%
Lipoxin
66%
Pro-resolution
66%
Chronic Inflammation
33%
Disease Onset
33%
Inflammatory Diseases
33%
Arachidonic Acid
33%
Lipoxygenase
33%
Disease Progression
33%
Eicosapentaenoic Acid
33%
Plasma Parameters
33%
Polyunsaturated Fatty Acids
33%
Docosahexaenoic Acid
33%
Vasculature
33%
Clinical Trials
33%
Inflammatory Mediators
33%
Tissue Homeostasis
33%
Acute Inflammation
33%
Debris
33%
Clinical Development
33%
Endogenous Lipids
33%
Lipid Signaling
33%
Potential Risk Factors
33%
Prevention Studies
33%
Cyclooxygenase-2
33%
Lipid Mediators
33%
Bioactive Lipids
33%
Cognitive Status
33%
Ischemic Stroke Patients
33%
Microglial Cells
33%
Switch-off
33%
Resolvins
33%
Chronic Neuroinflammation
33%
Immunomodulatory Molecules
33%
Neuroinflammation
33%
Drug Analogues
33%
Post-stroke Cognitive Impairment
33%
Self-limiting
33%
AD Prevention
33%
Pharmacology, Toxicology and Pharmaceutical Science
Inflammation
100%
Alzheimer's Disease
100%
Lipoxin A
100%
Lipoxin
66%
Nervous System Inflammation
66%
Chronic Inflammation
33%
Inflammatory Disease
33%
Amyloid Protein
33%
Arachidonic Acid
33%
Lipoxygenase
33%
Immunoglobulin
33%
Icosapentaenoic Acid
33%
Polyunsaturated Fatty Acid
33%
Docosahexaenoic Acid
33%
Cyclooxygenase 2
33%
Anti-Inflammatory Drug
33%
Clinical Trial
33%
Cognitive Defect
33%
Cerebrovascular Accident
33%
Brain Ischemia
33%
Drug Analog
33%
Neuroscience
Alzheimer's Disease
100%
Lipoxin A
100%
Lipoxin
66%
Amyloid Protein
33%
Blood Plasma
33%
Anti-Inflammatory
33%
Microglia
33%
Lipoxygenase
33%
Arachidonic Acid
33%
Intravenous Immunoglobulin
33%
Cognitive Disorders
33%
Polyunsaturated Fatty Acid
33%
Icosapentaenoic Acid
33%
Cerebrovascular Accident
33%
Cyclooxygenase 2
33%
Lipid Signaling
33%
Brain Ischemia
33%
Docosahexaenoic Acid
33%
Resolvin
33%
Risk Factor
33%